Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Baxter
Mallinckrodt
Johnson and Johnson
Express Scripts

Last Updated: January 21, 2022

DrugPatentWatch Database Preview

Hospira Inc Company Profile


Email this page to a colleague

« Back to Dashboard

Summary for Hospira Inc
International Patents:22
US Patents:2
Tradenames:66
Ingredients:55
NDAs:88
Drug Master File Entries: 32
Patent Litigation for Hospira Inc: See patent lawsuits for Hospira Inc

Drugs and US Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc OXACILLIN SODIUM oxacillin sodium INJECTABLE;INJECTION 203950-002 Dec 11, 2015 DISCN No No ⤷  Try it Free ⤷  Try it Free
Hospira Inc THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019211-002 Dec 14, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free
Hospira Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 202865-001 Sep 4, 2015 DISCN No No ⤷  Try it Free ⤷  Try it Free
Hospira Inc DAPTOMYCIN daptomycin POWDER;INTRAVENOUS 210282-001 Jun 21, 2021 RX Yes Yes 9,655,946 ⤷  Try it Free Y ⤷  Try it Free
Hospira Inc LEVOFLOXACIN levofloxacin INJECTABLE;INJECTION 078577-002 Aug 12, 2015 DISCN No No ⤷  Try it Free ⤷  Try it Free
Hospira Inc NOVAMINE 11.4% amino acids INJECTABLE;INJECTION 017957-003 Aug 9, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for HOSPIRA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16

Supplementary Protection Certificates for Hospira Inc Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0579826 02C0041 France ⤷  Try it Free PRODUCT NAME: ERTAPENEM SODIUM; REGISTRATION NO/DATE: EU/1/02/216/001 20020418
1856135 CR 2020 00018 Denmark ⤷  Try it Free PRODUCT NAME: FOSTAMATINIB OR A PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, OR A HYDRATE, SOLVATE OR N-OXIDE OF FOSTAMATINIB OR THE PHARMACEUTICALLY ACCEPTABLE SALT OF FOSTAMATINIB, ESPECIALLY FOSTAMATINIB DISODIUM, OPTIONALLY IN FORM OF A HYDRATE; REG. NO/DATE: EU/1/19/1405 20200113
1532149 8/2012 Austria ⤷  Try it Free PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3,7-DIHYDROPURIN-2,6-DION UND DESSEN SALZE, INSBES. LINAGLIPTIN; REGISTRATION NO/DATE: EU/1/11/707/001-011 (MITTEILUNG) 20110830
0290047 97C0108 Belgium ⤷  Try it Free PRODUCT NAME: MANGAFODIPIR TRISODIUM (ANHYDROUS) CORRESP. MANGAFODIPIR; REGISTRATION NO/DATE: EU/1/97/040/001 19970522
2377536 25/2013 Austria ⤷  Try it Free PRODUCT NAME: 4-AMINOPYRIDIN ODER DESSEN SALZE; REGISTRATION NO/DATE: EU/1/11/699/001-002 20110720
0481754 SPC/GB06/032 United Kingdom ⤷  Try it Free PRODUCT NAME: ENTECAVIR-(2-AMINO-1,9-DIHYDRO-9-((1S,3R,4S)-4-HYDROXY-3-(HYDROXYMETHYL)-2-METHYLENE CYCLOPENTYL)-6H-PURIN-6-ONE AND HYDRATES THEREOF, PARTICULARLY THE MONOHYDRATE; REGISTERED: UK EU/1/06/343/001 20060626; UK EU/1/06/343/002 20060626; UK EU/1/06/343/003 20060626; UK EU/1/06/343/004 20060626; UK EU/1/06/343/005 20060626
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Boehringer Ingelheim
Mallinckrodt
Merck
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.